FLUORESCENCE DIAGNOSIS AND PHOTODYNAMIC THERAPY IN COMBINED TREATMENT OF CHOLANGIOCARCINOMA

The results of the pilot study of combined treatment for non-resectable cholangiocarcinoma complicated with obstructive jaundice are represented this paper. Method included percutaneous transhepatic biliary drainage, endoscopic fluorescence diagnosis, photodynamic therapy of tumor stricture, and stenting of bile ducts. Fourteen patients who underwent the treatment in the surgery department clinic of I.M. Sechenov First Moscow State Medical University were enrolled in the study. Fluorescence diagnosis and photodynamic therapy were carried out using photosensitizers photosens (0.5 mg/kg), fotolon (1 mg/kg), and radachlorin (1 mg/kg). The average light dose for one session was 115±5 J/cm2. Fluorescence diagnosis using endoscopic video-fluorescence system for endoscopy and minimally invasive surgery allowed to obtain videoassisted fluorescence image of the tumor and to measure level of photosensitizer fluorescence in tumor in all patients. Malignant tumor was confirmed by morphological study in 12 patients, biopsy of material for morphological study failed in 2 patients with Klatskin tumor. The preliminary results of combined minimally invasive treatment were assessed as promising. The survival time in 4 patients after treatment accounted for 21, 17, 13 and 11 months, respectively. For now 5 patients are under follow-up. Follow-up periods are 13 and 19 months in 2 of them and from 4 to 6 months in 3 of them. Five patients with multiple distant metastases before the treatment died in 3±1 months after therapy. The average lifetime in the treatment group is 9.5 months up to date, however the duration is expected to be

longer because 5 of 14 patients are alive.

1. Vetshev P.S. The Diagnostic approach to Obstructive Jaundice, Rossiiskii zhurnal gastroenterologii, gepatologii, koloproktologii, 1999, No. 6, pp. 18-24. (in Russian).

2. Chistyakov S.S. Onkologiya dlya praktikuyushchikh vrachei [Oncology for practicing physicians]. Moscow, Tovarishchestvo nauchnykh izdanii KMK Publ., 2009. 634 p.

3. Maistrenko N.A., Sheiko S.B., Alentiev A.V., Azimov, F.H. Cholangiocellular cancer (diagnostics and treatment), Prakticheskaya onkologiya, 2008, Vol. 9, No. 4, pp. 229-236. (in Russian).

4. Isayama H., Tsujino T., Nakai Y., Sasaki T., Nakagawa K., Yamashita H., Aoki T., Koike K. Clinical benefit of radiation therapy and metallic stenting for unresectable hilar cholangiocarcinoma, World J Gastroenterol, 2012, Vol.18, pp. 2364-2370. doi: 10.3748/wjg.v18.i19.2364.

5. Shevchenko Y.L., Karpov O.E., Vetshev P.S., Maadi A.S. Alekseev K.I., Osipov A.S., Vasiliev I.V., Tyurbeev B.Ts. Application self-expanding nitinol stents in obstructive tumor genesis of icterus, Vestnik Natsional'nogo mediko-khirurgicheskogo Tsentra im. N.I. Pirogova, 2014, Vol. 9, No. 2, pp. 30-34. (in Russian).

6. Hucl T. Malignant biliary obstruction, Cas. Lek. Cesk, 2016, Vol. 155(1), pp. 30-7.

7. Khan S.A., Thomas H.C., Davidson B.R., Taylor-Robinson S.D. Cholangiocarcinoma, Lancet, 2005, Vol.366, No. 9493, pp. 1303-1305.

8. Вakhru M., Tekola B., Kahaleh M. Endoscopic palliation for pancreatic cancer, Cancers (Basel), 2011, Vol. 3, No. 2, pp. 1947-1956.

9. Lee T.Y., Cheon Y.K., Shim C.S. Current status of photodynamic therapy for bile duct cancer, Clin Endosc, 2013, Vol. 46(1), pp. 38-44. doi: 10.5946/ce.2013.46.1.38.

10. Quyn A.J., Ziyaie D., Polignano F.M., Tait I.S. Photodynamic therapy is associated with an improvement in survival in patients with irresectable hilar cholangiocarcinoma, HPB (Oxford), 2009, Vol. 11, pp. 570-577.

11. Tan Y., Zhu J.Y., Qiu B.A., Xia N.X., Wang J.H. Percutaneous biliary stenting combined with radiotherapy as a treatment for unresectable hilar cholangiocarcinoma, Oncol Lett, 2015, Vol. 10(4), pp. 2537-2542.

12. Kose F., Oguzkurt L., Besen A., Sumbul T., Sezer A., Karadeniz C., Disel U., Mertsoylu H., Ozyilkan O. Effectiveness of percutaneous metal stent placement in cholangiocarcinoma patients with midterm follow- up: Single center experience, Eur J Radiol, 2012, Vol. 81, pp. 1724- 1727. doi:10.1016/j.ejrad.2011.04.056.

13. Kipp B.R., Stadheim L.M., Halling S.A., Pochron N.L., Harmsen S., Nagorney D.M., Sebo T.J., Therneau T.M., Gores G.J., de Groen P.C., Baron T.H., Levy M.J., Halling K.C., Roberts L.R. A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures, Am J Gastroenterol, 2004, Vol. 99, pp. 1675-1681.

14. Kulezneva Yu.V., Bruslik S.V., Musaev G.H., Israilov R.E., Kirillova M.S. Percutaneous Modalities of Biliary Decompression: Development and Disputable Items Development and Disputable Items, Annaly khirurgicheskoi gepatologii, 2011, Vol. 16, No. 3, pp. 35-43. (in Russian).

15. Vishnevskiy V.A., Tarasyuk I.T. Diagnosis and Surgical treatment of Cancer of the proximal hepatic ducts (tumors Klatskin), Prakticheskaya onkologiya, 2004, Vol. 5, No. 2, pp. 126-134. (in Russian).

16. Galperin E.I., Vetshev P.S. Rukovodstvo po khirurgii zhelchnykh putei [Guidelines for biliary tract surgery]. Moscow, Vidar Publ., 2009. 568 p.

17. Okhotnikov O.I., Grigoriev S.N., Yakovleva M.V. Percutaneous Endobiliary Interventions in Obstructive Jaundise Syndrome in Obstructive Jaundise Syndrome, Annaly khirurgicheskoi gepatologii, 2011, Vol. 16, No. 3, pp. 44-49. (in Russian).

18. Jaganmohan S., Lee J.H. Self-expandable Metal Stents in Malignant Biliary Obstruction Surgical versus Endoscopic Biliary Drainage, Expert Rev Gastroenterol Hepatol, 2012, Vol. 6, No. 1, pp. 105-114.

19. Lobakov A.I., Stranadko E.F., Mokin M.V., Kruglov E.E., Denisov V.A., Sachechelashvili G.L., Zakharov Yu.I., Lavrova N.N. Possibilities of Photodynamic Therapy in the treatment of Cancer of major duodenal papilla, Annaly khirurgicheskoi gepatologii, 2005, Vol. 10, No. 1, pp. 86-89. (in Russian).

20. Rerknimitr R., Angsuwatcharakon P., Ratanachu-Ek T., Khor C.J., Ponnudurai R., Moon J.H., Seo D.W., Pantongrag-Brown L., Sangchan A., Pisespongsa P., et al. Asia- pacific consensus recommendations for endoscopic and interventional management of hilar cholangiocarcinoma, J Gastroenterol Hepatol, 2013, Vol. 28, pp. 593-607.

21. Höblinger A., Gerhardt T., Gonzalez-Carmona M.A., Hüneburg R., Sauerbruch T., Schmitz V. Feasibility and safety of long-term photodynamic therapy (PDT) in the palliative treatment of patients with hilar cholangiocarcinoma, Eur J Med Res, 2011, Vol. 16, pp. 391-395. doi: 10.1186/2047-783X-16-9-391.

22. Chissov V.I., Filonenko E. V. Fluorestsentnaya diagnostika i fotodinamicheskaya terapiya v klinicheskoi onkologii [Fluorescence Diagnosis and Photodynamic Therapy in clinical Oncology]. Moscow, Triumph Publ., 2012. 272 p.

23. Kniebühler G.1., Pongratz T., Betz C.S., Göke B., Sroka R., Stepp H., Schirra J. Photodynamic therapy for cholangiocarcinoma using low dose mTHPC (Foscan(®)), Photodiagnosis Photodyn Ther, 2013, Vol. 10(3), pp. 220-8. doi: 10.1016/j.pdpdt.2012.12.005.

24. Wentrup R., Winkelmann N., Mitroshkin A., Prager M., Voderholzer W., Schachschal G., Jürgensen C., Büning C. Photodynamic Therapy Plus Chemotherapy Compared with Photodynamic Therapy Alone in Hilar Nonresectable Cholangiocarcinoma, Gut Liver, 2016, Vol. 10(3), pp. 470-5. doi: 10.5009/gnl15175.

25. Levkin V., Gagarina N., Kharnas S., Musaev G., Shiryaev A., Bulgin D. Modern Technologies for Timely Detection and Differential Diagnosis of Gastric Cancer, New Aspects in Molecular and Cellular Mechanisms of Human Carcinogenesis, by Bulgin D. InTech Publ., 2016. doi: 10.5772/59826.

26. Chen Y.J., Jiang H.T., Cao J.Y. Influence of Photodynamic Therapy on Apoptosis and Invasion of Human Cholangiocarcinoma QBC939 Cell Line, Chin. Med. Sci. J., 2015, Vol. 30(4), pp. 252-9.

27. Tsyb A.F., Kaplan M.A., Romanenko Y.S., Popuchiev V.V. Klinicheskie aspekty fotodinamicheskoi terapii [Clinical aspects of Photodynamic Therapy]. Kaluga, Publ. of Nauch. liter-ry. N.F. Bochkarevoi, 2009. 204 p.

28. Ortner M.E., Caca K., Berr F., Liebetruth J., Mansmann U., Huster D., Voderholzer W., Schachschal G., Mössner J., Lochs H. Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study, Gastroenterology, 2003, Vol. 125(5), pp. 1355-63.

29. Makarov E.S., Nechushkin M.I., Dolgushin B.I., Fainstein I.A. Intraluminal Radiotherapy of the Locally Spread Cancer of the Extrahepatic Bile Ducts, Annaly khirurgicheskoi gepatologii, 2006, Vol. 11, No. 1, pp. 45-53.

30. Tapping C.R., Byass O.R., Cast J.E. Percutaneous transhepatic biliary drainage (PTBD) with or without stenting-complications, re-stent rate and a new risk stratification score, Eur Radiol, 2011, Vol. 21, pp. 1948- 1955. doi: 10.1007/s00330-011-2121-7.